Omnicare 3rtd-quarter profit rises 13 percent as lower costs offset revenue declineNovember 5th, 2009 Omnicare 3Q profit rises 13 percentCOVINGTON, Ky. — Omnicare Inc., which dispenses drugs to nursing homes and long-term care facilities, said Thursday its third-quarter profit rose 13 percent as lower costs and an income tax adjustment offset a dip in revenue.
Medicis reports profit as sales pick up and charges decrease; company raises 2009 forecastsNovember 4th, 2009 Acne, wrinkle treatments help Medicis post profitSCOTTSDALE, Ariz. — Medicis Pharmaceutical Corp.
Medco Health Solutions' 3rd-quarter profit jumps 13.5 percent on new clients, pricingNovember 3rd, 2009 Medco Health 3Q profit jumps 13.5 percentNEW YORK — Medco Health Solutions Inc., the largest U.S. pharmacy benefits manager, said Tuesday its profit rose 13.5 percent as the company gained new clients and benefited from price inflation of brand-name drugs.
Kindred posts 3Q profit and revenue ahead of Wall Street estimates, but outlook hits sharesNovember 2nd, 2009 Kindred turns 3Q profit, but outlook sinks sharesLOUISVILLE, Ky. — Health care services company Kindred Healthcare Inc.
Phase Forward posts 3rd-quarter profit decline, tops Wall Street's forecastOctober 29th, 2009 Phase Forward posts 3rd-quarter profit declineWALTHAM, Mass. — Phase Forward Inc., a provider of data management software for drug safety and clinical trials, reported its third-quarter profit sank nearly 50 percent, but still handily beat Wall Street's forecast.
Novamed shares fall as 3rd-quarter profit dips, earnings-per-share misses forecastsOctober 29th, 2009 Novamed shares fall on 3Q profit dipNEW YORK — Shares of ambulatory surgery center operator Novamed Inc. fell Thursday after the company reported a slight dip in third-quarter profit and earnings per share missed Wall Street expectations.
Illumina posts profit as merger charges come off its books but results, outlook miss viewOctober 27th, 2009 Illumina turns 3Q profit but outlook weakSAN DIEGO — Genetic analysis instrument maker Illumina Inc. reported a third-quarter profit on Tuesday, compared with a year-ago period which included hefty acquisition costs.
Inverness Medical turns profit in 3Q as flu revenue up almost sixfold, acquisitions lift salesOctober 27th, 2009 Surging flu revenue helps Inverness post 3Q profitWALTHAM, Mass. — Diagnostics company Inverness Medical Innovations Inc.
Hospira profit climbs on sales of generic chemotherapy treatment and other specialty drugsOctober 27th, 2009 more images
more imagesChemotherapy drug sales boost Hospira 3Q profitLAKE FOREST, Ill. — Hospira Inc.
3M posts weaker 3Q profit because of frugal US, European consumers but Asia offers a boostOctober 22nd, 2009 3M's 3Q weaker but Asia provides surprising boostNEW YORK — 3M Co., which makes everything from Post-It Notes to insect repellent, said Thursday strong sales of health care products in flu-wary Asia helped lift earnings beyond analyst expectations in the third quarter. As a result, the St.
Celgene's 3rd-quarter profit jumps 58 percent on cancer drug sales, tops forecastsOctober 22nd, 2009 Celgene 3Q profit surges on cancer drug salesSUMMIT, N.J. — Biotech drugmaker Celgene Corp.
Omnicell says 3rd-qtr profit slides sharply as product sales tumbleOctober 22nd, 2009 Omnicell 3Q profit falls as sales slideMOUNTAIN VIEW, Calif. — Omnicell Inc., which makes pharmacy-management systems and other devices, said Thursday its third-quarter profit fell sharply as product sales declined as health care firms remained cautious on equipment spending.
Affymetrix reports smaller 3rd-quarter loss, but results miss estimates, shares tumbleOctober 21st, 2009 Affymetrix posts smaller 3Q loss, but shares fallSANTA CLARA, Calif. — Affymetrix Inc., which makes genetic analysis technology, on Wednesday reported a narrower third-quarter loss, but the results missed Wall Street expectations, sending shares plunging in after-hours trading.
Drugstore.com reports a narrower loss in the third quarter as sales rise, margins improveOctober 20th, 2009 Drugstore.com posts narrower 3Q loss as sales riseBELLEVUE, Wash. — Online retailer Drugstore.com Inc.
Biogen Idec says Tysabri sales grew 21 pct, lower amortization expenses aided 3rd-qtr profitOctober 20th, 2009 Biogen 3Q profit beats views on smaller chargesCAMBRIDGE, Mass. — Biogen Idec says its profit jumped 34 percent in the third quarter due to lower amortization costs and increased sales of its multiple sclerosis drug Tysabri.
November 4th, 2009 at 11:50 pm
excellent blog for providing a platform for health engineering.